PBPK Analysis to Study the Impact of Genetic Polymorphism of NAT2 on Drug-Drug Interaction Potential of Isoniazid

被引：0
|
作者：
Ankit Balhara
Saranjit Singh
机构：
[1] National Institute of Pharmaceutical Education and Research (NIPER),Department of Pharmaceutical Analysis
来源：
Pharmaceutical Research | 2021年 / 38卷
关键词：
DDI; genetic polymorphism; isoniazid; N-acetyl transferase; PBPK modeling;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1485 / 1496
页数：11
相关论文
共 50 条
  • [1] PBPK Analysis to Study the Impact of Genetic Polymorphism of NAT2 on Drug-Drug Interaction Potential of Isoniazid
    Balhara, Ankit
    Singh, Saranjit
    PHARMACEUTICAL RESEARCH, 2021, 38 (09) : 1485 - 1496
  • [2] Dependence of Efavirenz- and Rifampicin-Isoniazid-Based Antituberculosis Treatment Drug-Drug Interaction on CYP2B6 and NAT2 Genetic Polymorphisms: ANRS 12154 Study in Cambodia
    Bertrand, Julie
    Verstuyft, Celine
    Chou, Monidarin
    Borand, Laurence
    Chea, Phalla
    Nay, Kuy Huong
    Blanc, Francois-Xavier
    Mentre, France
    Taburet, Anne-Marie
    JOURNAL OF INFECTIOUS DISEASES, 2014, 209 (03): : 399 - 408
  • [3] NAT2 gene polymorphism: covert drug interaction causing phenytoin toxicity
    Adithan, C.
    Subathra, A.
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2016, 143 : 542 - 544
  • [4] Effects of genetic polymorphism and drug-drug interaction on outcomes of clopidogrel treatment
    Chang, Yen-Lin
    Hsiao, Tzu-Hung
    Wu, Ming-Fen
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 460 - 460
  • [5] PBPK MODELING TO ASSESS DRUG-DRUG INTERACTION POTENTIAL OF VENGLUSTAT WITH CYP3A INHIBITORS
    Sharma, J.
    Li, L.
    Macha, S.
    Xu, C.
    Sahi, J.
    Zhang, Y.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 : S74 - S74
  • [6] Impact of Genetic Polymorphism on Drug-Drug Interactions Mediated by Cytochromes: A General Approach
    Tod, Michel
    Nkoud-Mongo, Christina
    Gueyffier, Francois
    AAPS JOURNAL, 2013, 15 (04): : 1242 - 1252
  • [7] Impact of Genetic Polymorphism on Drug-Drug Interactions Mediated by Cytochromes: A General Approach
    Michel Tod
    Christina Nkoud-Mongo
    François Gueyffier
    The AAPS Journal, 2013, 15 : 1242 - 1252
  • [8] Analysis and Evaluation of Potential Drug-Drug Interaction in the Meningitis Therapy
    Farmanullah
    Ullah, Irfan
    Izharullah
    Dar, Eshwa
    Alahmadi, Yaser M.
    Iqbal, Muhammad Omer
    Shaikh, Abdul Rasheed
    Sohail, Kashif
    Khan, Haroon
    Ahmed, Tahseen
    Parveen, Shumaila
    Alolayan, Sultan Othman
    LATIN AMERICAN JOURNAL OF PHARMACY, 2021, 40 (06): : 1315 - 1318
  • [9] The impact of PBPK modeling on prediction of drug drug interaction potential of a candidate drug with non linear pharmacokinetics
    Snoeys, Jan
    Van Houdt, Jos
    Sinha, Vikash
    Mannens, Geert
    Sterkens, Patrick
    Van Osselaer, Nancy
    Monshouwer, Mario
    DRUG METABOLISM REVIEWS, 2010, 42 : 120 - 121
  • [10] Utilizing PBPK Modeling to Evaluate the Potential of a Significant Drug-Drug Interaction Between Clopidogrel and Dasabuvir: A Scientific Perspective
    Arya, V.
    Zhao, P.
    Reynolds, K. S.
    Mishra, P.
    Younis, I. R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 102 (04) : 578 - 580
12345